卫生政策还是知识产权政策？关于C-91法案的争论。加拿大医疗保健协会。
Health policy or intellectual property policy? The fight over Bill C-91. Canadian Healthcare Association.
出版信息
Int J Health Care Qual Assur Inc Leadersh Health Serv. 1997;10(2-3):vii-x.
PMID:10169229
Abstract
Adapted from the Canadian Healthcare Association's submission to the House of Commons Standing Committee on Industry currently reviewing Bill C-91, an Act to amend the Patent Act. Discusses the controversy surrounding this legislation, which extended patent protection to brand-name drug manufacturers to 20 years before generic copies of pharmaceuticals can be introduced on to the market.
摘要
改编自加拿大医疗保健协会提交给下议院工业常务委员会的材料，该委员会目前正在审议《C-91法案》，即一项修订《专利法》的法案。文中讨论了围绕该立法的争议，该立法将品牌药制造商的专利保护延长至20年，之后仿制药才能投放市场。
Zotero 插件